Eli Lilly, Novo Nordisk intentionally targeted Americans with weight loss drugs, suit says Eli Lilly and Novo Nordisk intentionally targeted the American population with the sale of their weight loss drugs, according to the complaint, which claims the companies understood the vast financial potential of marketing a weight-loss medication in the United States. Defendants set on a course to create and expand the market for weight-loss medication by, among other things, advocating for obesity to be classified as a disease and thereby expanding the market for their drugs, the complaint says
Getting Started is Easy Submit Your Project Requirements We'll evaluate your compound, goals, and preferred specifications
If you are someone who struggles with gastrointestinal side effects on existing GLP-1 agonists , mazdutide may offer a more comfortable experience
Kraft gestiegen, Krper verbessert, durchgngig gut gefhlt
What topics do you want to explore
1,5-anhydroglucitol (1,5-AG) should be used only when there is a suspicion of postprandial hyperglycemia, even with normal HbA1c or fructosamine levels